Migraine
Not recruitingStudy on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
- Disease:Migraine
- Substances:Lu Ag09222
Czechia- Participants:18–64 years
- Substances:Lu Ag09222
- Sponsor:H. Lundbeck A/S
Rare diseases
Investigational molecules
Locations
Back to Czechia2 clinical trials in Litomysl, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)
Czechia
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on Invasive Extraintestinal Pathogenic Escherichia coli Disease prevention through vaccine development. Clinical trials are evaluating a novel ExPEC9V vaccine targeting multiple bacterial serotypes in older adults with urinary tract infection history.
The research specifically targets adults aged 60 and older, aiming to prevent invasive infections.
Innovative clinical trials exploring new therapeutic options for migraine prevention. The research focuses on evaluating LU AG90222, a novel treatment approach for patients who haven't responded to conventional preventative therapies.
This research represents a significant advancement in addressing treatment-resistant migraine cases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.